Aldo Magada – Trademark Portfolio

Entity Type: 01

Aldo Magada holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 2 filings in this category. The portfolio also extends into Class 14 (Jewelry) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include B and BIMBU.

CH-1162 Saint-Prex

Chemin des Oiseaux 11

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

B
B
Registered 2024
BIMBU
BIMBU
Registered 2023

Trademark Classifications

Aldo Magada's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (2 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

14
Jewelry (2 filings)

Precious metals and their alloys; jewellery, precious stones; horological instruments

18
Leather Goods (2 filings)

Leather and imitations of leather; animal skins, hides; trunks and travelling bags

Frequently Asked Questions

How many trademarks does Aldo Magada have?

Aldo Magada has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Aldo Magada file in?

Aldo Magada files trademarks across 3 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 14 (Jewelry), Class 18 (Leather Goods). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are Aldo Magada's most well-known trademarks?

Aldo Magada's registered trademark portfolio includes well-known marks such as B and BIMBU. These are among 2 currently registered trademarks in the portfolio.

What is Aldo Magada's trademark registration success rate?

Aldo Magada has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.